JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

Alberto Alvarez-Larrán, Beatriz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández-Boluda, Luz Martínez-Avilés, Concepción Fernández-Rodríguez, Montse Gómez, Luis Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado, Carlos Besses

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)

Abstract

The JAK2V617F allele burden has been identified as a risk factor for vascular events and myelofibrotic transformation in polycythemia vera (PV) and essential thrombocythemia (ET). However, all previous studies have evaluated a single time point JAK2V617F measurement. Therefore, the frequency and the clinical significance of changes in the JAK2V617F mutant load occurring during the disease evolution remain unknown. In the present study, JAK2V617F monitoring was performed during the follow-up of 347 patients (PV=163, ET=184). According to their JAK2V617F evolutionary patterns, patients were stratified as stable<50% (n=261), stable ≥50% (n=52), progressive increase (n=24) and unexplained decrease (n=10). After a 2,453 person-years follow-up, a total of 59 thrombotic events, 16 major hemorrhages, and 27 cases of myelofibrotic transformations were registered. At multivariate analyses, patients with a persistently high (≥50%) or unsteady JAK2V617F load during follow-up had an increased risk of myelofibrotic transformation (Incidence rate ratio [IRR]: 20.7, 95% CI: 6.5-65.4; P<0.001) and a trend for a higher incidence of thrombosis (IRR: 1.7, 1-3.3; P=0.05) than patients with a stable allele burden below 50%. In conclusion, JAK2V617F monitoring could be useful in patients with PV and ET for predicting disease's complications, especially myelofibrotic transformation. © 2014 Wiley Periodicals, Inc.
Original languageEnglish
Pages (from-to)517-523
JournalAmerican Journal of Hematology
Volume89
Issue number5
DOIs
Publication statusPublished - 1 Jan 2014

Fingerprint Dive into the research topics of 'JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events'. Together they form a unique fingerprint.

Cite this